Name: Dr Daniel Anderson
Cleave Biosciences

Events this person is speaking at:

Wednesday 7 September 2016

Inhibition of the AAA-ATPase p97 with the first in class inhibitor CB-5083 as a novel approach to treat cancer
Date: 7 September 2016, 11:00 - 12:00
Speaker : Dr Daniel Anderson (Cleave Biosciences)
Venue: NDM Building, Headington OX3 7FZ
Venue Details: Seminar Room
Organisers: Christina Woodward (Oxford Ludwig Institute, Nuffield Department of Medicine, University of Oxford), Mary Muers (Oxford Ludwig Institute, NDM Experimental Medicine), Alexandra Ward (University of Oxford, Oxford Ludwig Institute, NDM Experimental Medicine)
Host: Dr. John Christianson (Ludwig Cancer Research, Oxford)